Allarity Therapeutics Stock Investor Sentiment
| ALLR Stock | USD 0.96 0.04 4.00% |
Slightly above 65% of Allarity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Allarity Therapeutics suggests that many traders are alarmed. Allarity Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Allarity Therapeutics. Many technical investors use Allarity Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 35
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Allarity Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Allarity Therapeutics.
News SentimentBearish | Hype SentimentBearish | Insider SentimentWaiting |
Allarity Historical Sentiment
Although Allarity Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Allarity, such as negative comments on social media and news outlets, may cause fear in the market and push Allarity Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Allarity.
Allarity |
Allarity Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Allarity Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Allarity Therapeutics Historical Investor Sentiment
Investor biases related to Allarity Therapeutics' public news can be used to forecast risks associated with an investment in Allarity. The trend in average sentiment can be used to explain how an investor holding Allarity can time the market purely based on public headlines and social activities around Allarity Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Allarity Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Allarity Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Allarity Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Allarity Therapeutics.
Far too much social signal, news, headlines, and media speculation about Allarity Therapeutics that are available to investors today. That information is available publicly through Allarity media outlets and privately through word of mouth or via Allarity internal channels. However, regardless of the origin, that massive amount of Allarity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Allarity Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Allarity Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Allarity Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Allarity Therapeutics alpha.
Allarity Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Allarity Therapeutics, Inc. Short Interest Update | 01/17/2025 |
2 | Acquisition by Benjamin Laura of 25000 shares of Allarity Therapeutics at 1.01 subject to Rule 16b-3 | 01/22/2025 |
3 | Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle ... | 01/30/2025 |
4 | Allarity Therapeutics and Xilio Therapeutics Financial Contrast | 02/05/2025 |
5 | Acquisition by Alexander Epshinsky of 29496 shares of Allarity Therapeutics subject to Rule 16b-3 | 02/14/2025 |
6 | Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit | 02/26/2025 |
7 | Allarity Therapeutics Announces Board Authorization of 5 Million Share Repurchase Program | 03/03/2025 |
8 | Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission | 03/13/2025 |
9 | ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm | 03/19/2025 |
Additional Tools for Allarity Stock Analysis
When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.